By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AEterna Zentaris 

1405 Boul Du Parc-technologique

Quebec  Quebec  G1P 4P5  Canada
Phone: 418-652-8525 Fax: 418-652-0881


Company News
AEterna Zentaris (AEZS)' Zoptarelin Doxorubicin Meets Phase 2 Primary Endpoint In Men With Heavily Pretreated Castration And Taxane Resistant Prostate Cancer 9/28/2015 10:27:03 AM
AEterna Zentaris (AEZS) Announces TSX Approval Of Series B Warrant Amendment 9/28/2015 6:16:28 AM
AEterna Zentaris (AEZS) Announces Dismissal Of Class Action Lawsuit 9/24/2015 11:37:46 AM
AEterna Zentaris (AEZS) Announces Amendment To Series B Warrants 9/22/2015 10:53:56 AM
AEterna Zentaris (AEZS) To Present At Upcoming Rodman & Renshaw Annual Global Investment Conference In New York 9/3/2015 6:46:35 AM
AEterna Zentaris (AEZS) Second Quarter Financial And Operating Results 8/14/2015 6:37:08 AM
AEterna Zentaris (AEZS) Announces Data And Safety Monitoring Board Scheduled To Complete Second Interim Analysis Of The ZoptEC Phase 3 Trial In Endometrial Cancer In Early October 8/11/2015 7:06:11 AM
AEterna Zentaris (AEZS) To Announce Second Quarter 2015 Financial And Operating Results On August 13, 2015 8/6/2015 11:04:50 AM
AEterna Zentaris (AEZS) To Present At Upcoming Canaccord Genuity 35th Annual Global Growth Conference In Boston 8/4/2015 8:39:12 AM
AEterna Zentaris (AEZS) Announces Optimized Erk Inhibitor Compounds For Further Development 7/30/2015 10:10:05 AM